Literature DB >> 22618999

Axillary vein thrombosis as the first clinical manifestation of inflammatory breast cancer: report of a case.

Raffaele Serra1, Gianluca Buffone, Rossella Montemurro, Stefano de Franciscis.   

Abstract

Inflammatory breast cancer is a rare and aggressive form of breast cancer. Venous thromboembolism is often related to cancer conditions but this report presents a case in which the thromboembolic event predicted the diagnosis of cancer. A 48-year-old female was admitted with the evidence of acute right axillary vein thrombosis. There was also erythema and edema of the skin of the right breast. Further evidence revealed a case of inflammatory breast cancer. The patient underwent anticoagulant therapy, and neoadjuvant systemic chemotherapy was initiated. The patient underwent extensive unilateral mastectomy following neoadjuvant chemotherapy. Follow-up (after 2 months of anticoagulation therapy for deep vein thrombosis) revealed recanalization of the right axillary vein, without evidence of residual thrombus. A case of acute vein thrombosis as the first manifestation of breast cancer may delay the diagnosis and subsequent appropriate treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22618999     DOI: 10.1007/s00595-012-0196-7

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  6 in total

1.  Safety of a single duplex scan to exclude deep venous thrombosis.

Authors:  B Wolf; D M Nichols; J L Duncan
Journal:  Br J Surg       Date:  2000-11       Impact factor: 6.939

2.  Inflammatory breast cancer presenting with acute central venous thrombosis: a case report.

Authors:  Ralph Burton Pfeiffer; William Henry Barber
Journal:  Am Surg       Date:  2002-06       Impact factor: 0.688

3.  Management of inflammatory breast cancer after neoadjuvant chemotherapy.

Authors:  Soumya Abrous-Anane; Alexia Savignoni; Caroline Daveau; Jean-Yves Pierga; Chantal Gautier; Fabien Reyal; Remi Dendale; François Campana; Youlia M Kirova; Alain Fourquet; Marc A Bollet
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-05-17       Impact factor: 7.038

4.  Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial.

Authors:  S Schulman; P Lindmarker
Journal:  N Engl J Med       Date:  2000-06-29       Impact factor: 91.245

5.  Sentinel lymph node biopsy after neoadjuvant chemotherapy in inflammatory breast cancer.

Authors:  Samir Hidar; Mohamed Bibi; Olfa Gharbi; Sameh Tebra; Amel Trabelsi; Sadok Korbi; Nouredine Bouaouina; Slim Ben Ahmed; Hédi Khaïri
Journal:  Int J Surg       Date:  2009-05-03       Impact factor: 6.071

6.  Circulating tumour cells are associated with increased risk of venous thromboembolism in metastatic breast cancer patients.

Authors:  M Mego; U De Giorgi; K Broglio; S Dawood; V Valero; E Andreopoulou; B Handy; J M Reuben; M Cristofanilli
Journal:  Br J Cancer       Date:  2009-11-03       Impact factor: 7.640

  6 in total
  4 in total

Review 1.  Inflammatory breast cancer clusters: A hypothesis.

Authors:  Paul H Levine; Salman Hashmi; Ashley A Minaei; Carmela Veneroso
Journal:  World J Clin Oncol       Date:  2014-08-10

2.  Incidence and Risk Factors for Venous Thromboembolism in Female Patients Undergoing Breast Surgery.

Authors:  Ambrogio P Londero; Serena Bertozzi; Carla Cedolini; Silvia Neri; Michela Bulfoni; Maria Orsaria; Laura Mariuzzi; Alessandro Uzzau; Andrea Risaliti; Giovanni Barillari
Journal:  Cancers (Basel)       Date:  2022-02-16       Impact factor: 6.639

Review 3.  Upper extremity vein thrombosis: an alert symptom of breast cancer in elderly patients. Experience on personal casuistry and review of the literature.

Authors:  Raffaele Serra; Rita Compagna; Raffaele Grande; Paolo Perri; Gianluca Buffone; Vincenzo Gasbarro; Antonello Accurso; Michele Danzi; Giovanni Aprea; Bruno Amato; Stefano de Franciscis
Journal:  BMC Surg       Date:  2013-10-08       Impact factor: 2.102

4.  Syndecan-1 Promotes Angiogenesis in Triple-Negative Breast Cancer through the Prognostically Relevant Tissue Factor Pathway and Additional Angiogenic Routes.

Authors:  Eyyad Nassar; Nourhan Hassan; Eslam A El-Ghonaimy; Hebatallah Hassan; Mahmoud Salah Abdullah; Theresa V Rottke; Ludwig Kiesel; Burkhard Greve; Sherif Abdelaziz Ibrahim; Martin Götte
Journal:  Cancers (Basel)       Date:  2021-05-12       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.